DE69609316T2 - Verfahren zur markierung von intracytoplasmatischen molekülen - Google Patents

Verfahren zur markierung von intracytoplasmatischen molekülen

Info

Publication number
DE69609316T2
DE69609316T2 DE69609316T DE69609316T DE69609316T2 DE 69609316 T2 DE69609316 T2 DE 69609316T2 DE 69609316 T DE69609316 T DE 69609316T DE 69609316 T DE69609316 T DE 69609316T DE 69609316 T2 DE69609316 T2 DE 69609316T2
Authority
DE
Germany
Prior art keywords
cell
fetal
molecule
intracytoplasmic
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69609316T
Other languages
German (de)
English (en)
Other versions
DE69609316D1 (de
Inventor
Diana W. Bianchi
Mary Ann Demaria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tufts Medical Center Inc
Original Assignee
New England Medical Center Hospitals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Hospitals Inc filed Critical New England Medical Center Hospitals Inc
Application granted granted Critical
Publication of DE69609316D1 publication Critical patent/DE69609316D1/de
Publication of DE69609316T2 publication Critical patent/DE69609316T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69609316T 1995-02-14 1996-02-09 Verfahren zur markierung von intracytoplasmatischen molekülen Expired - Fee Related DE69609316T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/388,533 US5648220A (en) 1995-02-14 1995-02-14 Methods for labeling intracytoplasmic molecules
PCT/US1996/001806 WO1996025486A1 (en) 1995-02-14 1996-02-09 Methods for labeling intracytoplasmic molecules

Publications (2)

Publication Number Publication Date
DE69609316D1 DE69609316D1 (de) 2000-08-17
DE69609316T2 true DE69609316T2 (de) 2001-03-01

Family

ID=23534506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609316T Expired - Fee Related DE69609316T2 (de) 1995-02-14 1996-02-09 Verfahren zur markierung von intracytoplasmatischen molekülen

Country Status (12)

Country Link
US (1) US5648220A (https=)
EP (2) EP0992578A1 (https=)
JP (1) JPH11500010A (https=)
AT (1) ATE194647T1 (https=)
AU (1) AU4866896A (https=)
CA (1) CA2212796A1 (https=)
DE (1) DE69609316T2 (https=)
DK (1) DK0813594T3 (https=)
ES (1) ES2149453T3 (https=)
GR (1) GR3034378T3 (https=)
PT (1) PT813594E (https=)
WO (1) WO1996025486A1 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2414626A1 (en) * 2000-07-04 2002-01-10 Bioimage A/S A method for extracting quantitative information relating to interactions between cellular components
EP2359689B1 (en) 2002-09-27 2015-08-26 The General Hospital Corporation Microfluidic device for cell separation and use thereof
US20050266433A1 (en) * 2004-03-03 2005-12-01 Ravi Kapur Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
EP1874920A4 (en) * 2005-04-05 2009-11-04 Cellpoint Diagnostics DEVICES AND METHOD FOR ENRICHING AND CHANGING CIRCULATING TUMOR CELLS AND OTHER PARTICLES
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
WO2011146632A1 (en) 2010-05-18 2011-11-24 Gene Security Network Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
CN103608466B (zh) 2010-12-22 2020-09-18 纳特拉公司 非侵入性产前亲子鉴定方法
RU2671980C2 (ru) 2011-02-09 2018-11-08 Натера, Инк. Способы неинвазивного пренатального установления плоидности
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
CA2945962C (en) 2014-04-21 2023-08-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
WO2017057076A1 (ja) * 2015-09-28 2017-04-06 富士フイルム株式会社 有核赤血球の取得方法および有核赤血球の識別方法
RU2760913C2 (ru) 2016-04-15 2021-12-01 Натера, Инк. Способы выявления рака легкого
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
JP2018183095A (ja) * 2017-04-26 2018-11-22 株式会社エンプラス 胎児由来造血前駆細胞の単離方法、および胎児の染色体異常の可能性を試験する方法
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180814A (en) * 1984-01-31 1993-01-19 Akzo N.V. Tumor specific monoclonal antibodies
US4910131A (en) * 1987-12-23 1990-03-20 Mellman Ira S Idiotype and anti-idiotype antibodies useful in virus detection
DK172110B1 (da) * 1988-04-15 1997-10-27 Gen Hospital Corp Fremgangsmåde til isolation af mutanter af DNA-sekvenser og anvendelsen heraf til identifikation af celleoverfladeproteiner
US5288477A (en) * 1991-09-27 1994-02-22 Becton, Dickinson And Company Method for prognosticating response to cancer therapy
US5422277A (en) * 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
US5387520A (en) * 1992-08-27 1995-02-07 Worcester Foundation For Experimental Biology Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors
AU7474394A (en) * 1993-07-19 1995-02-20 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization

Also Published As

Publication number Publication date
EP0992578A1 (en) 2000-04-12
ES2149453T3 (es) 2000-11-01
JPH11500010A (ja) 1999-01-06
CA2212796A1 (en) 1996-08-22
AU4866896A (en) 1996-09-04
DK0813594T3 (da) 2000-10-02
EP0813594A1 (en) 1997-12-29
US5648220A (en) 1997-07-15
EP0813594B1 (en) 2000-07-12
DE69609316D1 (de) 2000-08-17
GR3034378T3 (en) 2000-12-29
EP0813594A4 (https=) 1997-12-29
PT813594E (pt) 2000-11-30
WO1996025486A1 (en) 1996-08-22
ATE194647T1 (de) 2000-07-15

Similar Documents

Publication Publication Date Title
DE69609316T2 (de) Verfahren zur markierung von intracytoplasmatischen molekülen
DE69031984T2 (de) Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna
DE69131181T2 (de) Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulation
DE69434942T2 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
DE68918004T2 (de) Verfahren zur Analyse von Zellbestandteilen in einer Flüssigkeit.
DE69622696T2 (de) Zellzählung durch einen immunoassay
DE3888779T2 (de) Immuntestsatz und -verfahren für ganze Zellen.
DE60208341T2 (de) Multidimensionale Analyse von Leukozyten
DE69329353T2 (de) Verfahren zur Herstellung und Analyse von Leukozyten in Vollblut unter Verwendung der Durchflusszytometrie
DE69501326T2 (de) Differentielle expansion von fötalen stamzellen im mütterlichen kreislauf zur verwendung in der pränatalen genetischen analyse
DE69924472T2 (de) Selektion von reifem sperma durch membranoberflächen-determinanten
EP0597068B1 (de) Verfahren zur pränataldiagnostik genetischer anomalien
Rodríguez de Alba et al. Prenatal diagnosis on fetal cells obtained from maternal peripheral blood: report of 66 cases
DE19859912C2 (de) Testsystem zur Erkennung verschiedener Marker, seine Herstellung sowie Verwendung
DE69013730T2 (de) Für ganze Zellen geeigneter Satz und Verfahren zu enzymatischen Bestimmungen.
Witonsky et al. Immunologic analysis of blood samples obtained from horses and stored for twenty-four hours
DE68928085T2 (de) Verfahren zur auslese bestimmter zellen oder zellgebilden anhand von populationen mit ausgewählten merkmalen
DE69527289T2 (de) Verfahren und Vorrichtung zur Bestimmung der Fruchtarbarkeit von Spermatozoenproben
CA3096539C (en) METHODS AND COMPOSITIONS FOR DETERMINING THE PRESENCE OR ABSENCE OF DNA ABERRATIONS
US20200326331A1 (en) Methods and compositions for determining the presence or absence of dna aberrations
EP2291658B1 (de) Durchflusszytometrisches verfahren zur bestimmung von gesamtleukozytenzahl und trombozytenzahl sowie zur leukozytendifferenzierung in blutproben von vögeln
EP0627626B1 (de) Nachweis von viralen oder bakteriellen Antigenen mittels Durchflusscytometrie
US20250283166A1 (en) Methods and compositions for identifying dna aberrations
AU3016700A (en) Methods for labeling intracytoplasmic molecules
DE10102687A1 (de) Trisomie 13-Diagnostik-Kit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee